CHPA supports a review of existing rules and coordination efforts to identify opportunities that could mitigate shortage risks during times of peak need. Emerging from the COVID-19 pandemic offers a pivotal moment for officials at various levels of government to explore whether targeted steps could facilitate supply network resilience for key over-the-counter healthcare commodities during future public emergencies.
CHPA supports a review of existing rules and coordination efforts to identify opportunities that could mitigate shortage risks during times of peak need.
Learn about CHPA's current slate of federal legislative priorities including OTC regulatory reform, dietary supplement regulation modernization, supply chain and product integrity, and more.
